Semaglutide exposure in early pregnancy and pregnancy outcomes: A case report and review of literature

Key Points

• Positive pregnancy outcomes were observed despite semaglutide exposure during early pregnancy, suggesting potential safety.
• The review highlights the importance of monitoring glycemic control in pregnancies affected by hormonal treatments and medications.
• Analysis of previous cases shows that careful management could mitigate risks associated with exposure to semaglutide.
• Pregnancy outcomes among this population indicate that further investigation is needed to establish safety parameters.